jueves, 2 de julio de 2009

Investigación clínica: Mejor qué...?

Mas...


La Doctora Marcia Angell, quien fue directora de New England Journal of Medicine (NEJM) y autora de "The Truth About Drug Companies" (Video, 52 min.) es la responsable de esta tajante afirmación...

Parece que las cosas ahora van en serio en EE.UU. a pesar de:

Drugmakers have recently bolstered lobbying efforts aimed at deterring the US government from using comparative drug studies as a possible means of reducing healthcare costs.


Según informa
:

In a highly anticipated report, released Tuesday morning, a panel assembled by the Institute of Medicine released a list of 100 health topics that it said should get high priority as the Obama administration proceeded with a plan to spend $1.1 billion in comparing the effectiveness of competing drugs, medical devices, operations and other treatments for specific health conditions.

Más...

No hay comentarios: